Thomas Strüngmann predicts price drop for weight-loss drugs

BioNTech co-founder Thomas Strüngmann predicts an upcoming price drop for weight-loss drugs.

Published 7h1 sourceNotable

≈ 16sSpeed

The fact

These treatments, like GLP-1 injections, are increasingly popular but remain expensive.

Strüngmann mentions innovations that could make these products more affordable.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on September 12, 2026